Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Flare Therapeutics
Biotech
Ex-J&J research chief lands at FogPharma—Chutes & Ladders
Former J&J research chief Mammen lands at FogPharma; AMT CEO departs after another layoff wave; Flare fills out C-suite following financing round.
Max Bayer
,
Gabrielle Masson
Mar 31, 2023 9:30am
Flare fires up with $123M series B and 3 Big Pharmas in tow
Mar 22, 2023 6:30am
Amgen vet to be CMO at Affini-T—Chutes & Ladders
Jul 29, 2022 9:30am
$1.1B fund at Third Rock Ventures will go to 10 new biotechs
Jun 15, 2022 6:30am
Moderna plucks Merck marketing head for CCO job—Chutes & Ladders
Apr 29, 2022 9:00am
Third Rock leads $82M series A for startup Flare Therapeutics
May 13, 2021 7:00am
